Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy ...
Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on ...
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
ALTOONA, Pa. (WTAJ) — Cancer patients in Central Pennsylvania now have greater access to an advanced prostate cancer treatment with the launch of Pluvicto at UPMC Altoona. Beginning in April, UPMC ...
Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...
About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...
In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...
Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder PURPOSE: To assess whether failure to maintain local control (LC) of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results